Access to care for adults living with spinal muscular atrophy in the UK

Robert Muni-Lofra1, Holly Borland1, Katie Nevin2

  • 1The John Walton Muscular Dystrophy Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, The Newcastle University, Newcastle upon Tyne, UK.

BMJ Neurology Open
|June 29, 2026
PubMed

Insights

Adults with spinal muscular atrophy (SMA) often have significant health issues but do not consistently receive recommended care. Improving care provision in adult SMA services is crucial for equitable management throughout life.

Area of Science:

  • Neurology
  • Genetics
  • Clinical Medicine

Background:

  • Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disorder characterized by motor neuron loss.
  • Current care guidelines for SMA are primarily based on pediatric best practices, with limited evidence for adult care.
  • Adult SMA patient care provision needs evaluation against established standards.

Purpose of the Study:

  • To assess the clinical features of adult SMA patients.
  • To evaluate the alignment of current care provision with existing SMA standards of care.
  • To identify gaps in care for adults with SMA.

Main Methods:

  • Cross-sectional analysis of a longitudinal registry cohort.
  • Inclusion of 426 patients with genetically confirmed SMA.
  • Data collection on respiratory function, bulbar involvement, musculoskeletal complications, and daily living support.

Main Results:

  • High prevalence of respiratory impairment, bulbar dysfunction, and contractures observed in adults with SMA.
  • Significant limitations in activities of daily living were reported.
  • Care provision did not consistently align with recommended SMA standards, particularly in respiratory support, physiotherapy, and nutritional management.

Conclusions:

  • Current standards of care application is inconsistent in the adult SMA population.
  • There are notable gaps in accessing recommended care, including respiratory support, physiotherapy, and nutritional management.
  • Improved translation of care into adult services is necessary for comprehensive and equitable SMA management across the lifespan.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...